These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7041952)

  • 1. Demonstration of urokinase-related fibrinolytic activity in human plasma.
    Wijngaards G; Kluft C; Groeneveld E
    Br J Haematol; 1982 May; 51(1):165-9. PubMed ID: 7041952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic plasma fibrinolysis: involvement of urokinase-related activity in the factor XII-independent plasminogen proactivator pathway.
    Kluft C; Wijngaards G; Jie AF
    J Lab Clin Med; 1984 Mar; 103(3):408-19. PubMed ID: 6199446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of urokinase activity in plasma with a chromogenic substrate.
    Hayashi S; Yamada K
    Thromb Res; 1981 Jun 1-25; 22(5-6):573-8. PubMed ID: 6171046
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinase.
    Liebman HA; Carfagno MK; Weitz IC; Berard P; Diiorio JM; Vosburgh E; Simms RW
    Am J Clin Pathol; 1992 Nov; 98(5):534-41. PubMed ID: 1485607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic studies in 13 unrelated families with factor XII deficiency.
    Rodeghiero F; Castaman G; Ruggeri M; Cazzavillan M; Ferracin G; Dini E
    Haematologica; 1991; 76(1):28-32. PubMed ID: 2055558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of high and low molecular weight urokinase in plasma.
    Murano G; Aronson D; Williams L; Brown L
    Blood; 1980 Mar; 55(3):430-6. PubMed ID: 6444529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material.
    Barlow GH; Marder VJ
    Thromb Res; 1980 May 1-15; 18(3-4):431-7. PubMed ID: 6998041
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase.
    Tissot JD; Schneider P; Hauert J; Ruegg M; Kruithof EK; Bachmann F
    J Clin Invest; 1982 Dec; 70(6):1320-3. PubMed ID: 6757269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
    Moniwa N
    Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1984 Jul; 37(7):772-7. PubMed ID: 6235248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    Agents Actions Suppl; 1992; 38 ( Pt 2)():292-8. PubMed ID: 1462834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of two types of protein immunochemically related to urinary urokinase occurring in human plasma.
    Binnema DJ; Dooijewaard G; van Iersel JJ
    Biochem Biophys Res Commun; 1987 Jan; 142(1):162-8. PubMed ID: 3101686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood urokinase plasminogen activator system in chronic urticaria.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Arch Dermatol Res; 2007 Jan; 298(8):409-11. PubMed ID: 17102952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of placental urokinase inhibitor in toxemia of pregnancy.
    Terao T; Kobayashi T
    Biol Res Pregnancy Perinatol; 1983; 4(4):145-51. PubMed ID: 6360225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of urokinase from human plasma.
    Wun TC; Schleuning WD; Reich E
    J Biol Chem; 1982 Mar; 257(6):3276-83. PubMed ID: 7037781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological characterization of plasminogen activators in human mixed saliva.
    Kjaeldgaard A; Kjaeldgaard M
    Acta Physiol Scand; 1986 Mar; 126(3):443-7. PubMed ID: 3515850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of plasma fibrinolysis after intrarectal administration of high molecular weight urokinase and its derivative.
    Sumi H; Maruyama M; Yoneta T; Mihara H
    Acta Haematol; 1983; 70(5):289-95. PubMed ID: 6414221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosorption method of urokinase determination].
    Isachenkov VA; Vakulina OP; Tomilin VA
    Vopr Med Khim; 1988; 34(6):133-6. PubMed ID: 3070932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on activator formation in human plasma with streptokinase. III. Investigation of activator kinetics in undiluted plasma in terms of urokinase equivalents.
    Martin M
    Thromb Haemost; 1976 Dec; 36(3):566-81. PubMed ID: 138962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.